Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.05
+0.09 (0.64%)
Nov 4, 2024, 4:00 PM EST - Market closed

Takeda Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Net Income
289,996144,067317,017230,059376,00544,241
Upgrade
Depreciation & Amortization
725,890695,415638,839583,151559,671583,649
Upgrade
Other Amortization
32,58732,58725,561---
Upgrade
Loss (Gain) From Sale of Assets
-5,709-1,780-6,797-7,174-232,102-17,346
Upgrade
Asset Writedown & Restructuring Costs
59,379150,01764,39454,51525,452101,882
Upgrade
Loss (Gain) From Sale of Investments
23,07920,7573,991-11,19559,277-18,387
Upgrade
Loss (Gain) on Equity Investments
-3,619-6,4738,63015,367-7623,987
Upgrade
Stock-Based Compensation
73,83470,87160,67243,37437,66329,122
Upgrade
Other Operating Activities
-61,481-133,114-109,887116,403-90,740-194,588
Upgrade
Change in Accounts Receivable
30,40615,10475,127127,294-9,316-34,826
Upgrade
Change in Inventory
-89,023-115,743-79,155-46,14825,978137,492
Upgrade
Change in Accounts Payable
2,705-9,895-84,804125,15736,620-29,932
Upgrade
Change in Other Net Operating Assets
-201,738-145,46963,568-107,698222,49944,458
Upgrade
Operating Cash Flow
876,306716,344977,1561,123,1051,010,931669,752
Upgrade
Operating Cash Flow Growth
-9.02%-26.69%-13.00%11.10%50.94%103.89%
Upgrade
Capital Expenditures
-198,530-175,420-140,657-123,252-111,206-127,082
Upgrade
Sale of Property, Plant & Equipment
3078,6069621,81546,45312,578
Upgrade
Cash Acquisitions
----49,672--4,890
Upgrade
Divestitures
27,92419,9597,95828,196530,388461,546
Upgrade
Sale (Purchase) of Intangibles
-141,386-305,310-493,032-62,785-125,262-90,628
Upgrade
Investment in Securities
-1,7311,25512,1038,58062,00841,851
Upgrade
Other Investing Activities
-55,161-12,9525,564-1,007-8,851-1,256
Upgrade
Investing Cash Flow
-368,577-463,862-607,102-198,125393,530292,119
Upgrade
Short-Term Debt Issued
-277,00040,000---
Upgrade
Long-Term Debt Issued
-100,00075,000249,3341,179,515496,190
Upgrade
Total Debt Issued
1,151,460377,000115,000249,3341,179,515496,190
Upgrade
Short-Term Debt Repaid
----2-149,043-351,223
Upgrade
Long-Term Debt Repaid
--375,487-400,071-849,809-1,690,976-731,057
Upgrade
Total Debt Repaid
-732,177-375,487-400,071-849,811-1,840,019-1,082,280
Upgrade
Net Debt Issued (Repaid)
419,2831,513-285,071-600,477-660,504-586,090
Upgrade
Repurchase of Common Stock
-1,882-2,326-26,929-77,531-2,141-3,737
Upgrade
Common Dividends Paid
-294,686-287,188-279,416-283,665-283,357-282,582
Upgrade
Dividends Paid
-294,686-287,188-279,416-283,665-283,357-282,582
Upgrade
Other Financing Activities
-72,362-66,415-117,732-108,592-142,352-132,804
Upgrade
Financing Cash Flow
50,353-354,416-709,148-1,070,265-1,088,354-1,005,213
Upgrade
Foreign Exchange Rate Adjustments
-17,11926,20422,92928,75812,501-21,766
Upgrade
Miscellaneous Cash Flow Adjustments
-----629
Upgrade
Net Cash Flow
540,963-75,730-316,165-116,527328,608-64,479
Upgrade
Free Cash Flow
677,776540,924836,499999,853899,725542,670
Upgrade
Free Cash Flow Growth
-16.34%-35.33%-16.34%11.13%65.80%116.37%
Upgrade
Free Cash Flow Margin
14.91%12.69%20.77%28.01%28.14%16.49%
Upgrade
Free Cash Flow Per Share
425.38342.28532.85633.95571.79346.49
Upgrade
Cash Interest Paid
92,962100,375108,555108,207107,350127,211
Upgrade
Cash Income Tax Paid
167,919202,039185,966140,423201,687226,768
Upgrade
Levered Free Cash Flow
446,475115,508480,297929,111783,893929,414
Upgrade
Unlevered Free Cash Flow
520,927187,628553,4051,005,631865,6461,022,545
Upgrade
Change in Net Working Capital
380,623439,427-74,378-189,748-237,986-441,165
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.